Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China · Delayed Price · Currency is CNY
29.61
-0.73 (-2.41%)
Oct 29, 2026, 3:00 PM CST

SHE:300957 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
543.66505.72503.05756.81,051862.92
Depreciation & Amortization
183.75183.75189.82137.8958.2358.53
Other Amortization
83.8983.8944.4437.2-14.86
Loss (Gain) From Sale of Assets
-2.57-2.575.04-0.46--0.52
Asset Writedown & Restructuring Costs
34.5534.55115.69--0.04
Loss (Gain) From Sale of Investments
-106.25-106.25-99.97-47.12--29.63
Provision & Write-off of Bad Debts
-2.01-2.0112.412.97--
Other Operating Activities
-120.8642.23-69.6129.6-340.1217.24
Change in Accounts Receivable
263.42263.42-310.03-348.62--45.1
Change in Inventory
104.81104.81254.89-121.42--221.43
Change in Accounts Payable
-113.12-113.1292.5162.54-490.74
Change in Other Net Operating Assets
-----5.27
Operating Cash Flow
851.44976.6694.87610.44769.451,153
Operating Cash Flow Growth
-24.67%40.54%13.83%-20.66%-33.25%167.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-93.58-482.99-378.38-274.28-353.42-270.68
Sale of Property, Plant & Equipment
0.250.313.482.890.010.23
Cash Acquisitions
--0.01-493.5-7.47-6.5
Investment in Securities
-224.64253.85-758.94188.09261.69-2,300
Other Investing Activities
41.4390.749.9158.7580.7118.83
Investing Cash Flow
-276.54-138.13-1,084-518.06-18.49-2,558

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-742.48837.71105.45--
Total Debt Issued
691.64742.48837.71105.45--
Long-Term Debt Repaid
--773.11-388.87-100.64-64.72-42.89
Lease Payments
-82.26-82.26-78.36-76.44-64.72-42.89
Total Debt Repaid
-801.46-773.11-388.87-100.64-64.72-42.89
Net Debt Issued (Repaid)
-109.82-30.63448.844.81-64.72-42.89
Issuance of Common Stock
-----2,905
Repurchase of Common Stock
---124.88-109.84--
Common Dividends Paid
-348.67-265.64-262.52-339.14-254.16-190.62
Other Financing Activities
-129.13-0.76-8.97-14.3-0.78-7.58
Financing Cash Flow
-587.62-297.0352.47-458.47-319.662,664

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-3.54-2.1-1.23-0.720.03-0
Net Cash Flow
-16.26539.34-337.82-366.81431.321,258

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
757.86493.61316.48336.16416.02882.04
Free Cash Flow Growth
33.27%55.97%-5.85%-19.20%-52.83%158.23%
Free Cash Flow Margin
13.70%9.21%5.52%5.87%8.30%21.93%
Free Cash Flow Per Share
1.801.170.760.800.982.17
Levered Free Cash Flow
585.42279.491.1770.0330.36612.5
Unlevered Free Cash Flow
596.8290.83102.1673.1333.33615.12
Free Cash Flow After Leases
675.61411.35238.12259.72351.3839.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
596.28593.45673.76652.43616.71490.75
Change in Working Capital
237.29237.29-6-316.43-229.26